5-10
2026
影响因子区间
—
平台估算
5%
2025
中国作者发文占比
3150 CHF
收费
期刊简介:Targeted Oncology addresses physicians and scientists committed to oncology and cancer research by providing a programme of articles on molecularly targeted pharmacotherapy in oncology. The journal includes:Original Research Articles on all aspects of molecularly targeted agents for the treatment of cancer, including immune checkpoint inhibitors and related approaches.Comprehensive narrative Review Articles and shorter Leading Articles discussing relevant clinically established as well as emerging agents and pathways.Current Opinion articles that place interesting areas in perspective.Therapy in Practice articles that provide a guide to the optimum management of a condition and highlight practical, clinically relevant considerations and recommendations.Systematic Reviews that use explicit, systematic methods as outlined by the PRISMA statement.Adis Drug Reviews of the properties and place in therapy of both newer and established targeted drugs in oncology.
【译文】针对肿瘤学的研究人员和医生,通过提供关于肿瘤学分子靶向药物治疗的文章系列,该期刊涵盖了包括免疫检查点抑制剂在内的所有分子靶向治疗药物的研究,以及相关的治疗方法和途径。

| 指标 | 当前值 | 近三年趋势 |
|---|---|---|
| JCR分区 | Q1 | 暂无 |
| 影响因子区间 | 5-10 | 暂无 |